摘要
本文对107例涎腺恶性肿瘤患者进行临床分析。属于Ⅲ、Ⅳ期的病人占85％。为术后放疗或化疗和单纯放疗两组,5年随访率为96.2％。3、5、10年的生存率分别为53.2％,39.2％和10.2％。单纯放疗组和术后加放疗化疗组的5年生存率分别为25.0％和50％。分析认为对腺样囊性癌、粘液表皮癌及肿瘤残存者应采用术后放疗。鳞状细胞癌和腺癌应加用化疗。涎腺癌除病变位于颌下者外,原则上不作选择性颈清扫。
One hundred and seven cases of malignant salivary tumor are analyzed. Eightyfive per cent of them presented with stage Ⅲ or Ⅳ disease. The follow-up rate was 96.2%. The 3-, 5-and 10-year survival rates were 53.2%, 39.2% and 10.2% respectively. The 5-year survival rate of patients treated by radiotherapy alone was25.0%, and by surgery combined with postoperative chemotherapy and/or radiotherapy was 50%. It is indicated that postoperative radiotherapy is mandatory for those of adenoid cystic carcinoma, mucoepidermoid carcinoma and residual carcinoma. Postoperative chemotherapy is advisable for squamous cell carcinoma and adenocarcinoma. The selective neck dissection is not necessary unless the tumor is submandihular in location.
出处
《中国肿瘤临床》
CAS
CSCD
北大核心
1991年第2期80-82,共3页
Chinese Journal of Clinical Oncology
关键词
涎腺肿瘤
预后
Malignant tumors Salivary gland Clinical analysis
